Advisory Board June 14, 2023

Lawsuits from Merck and the U.S. Chamber of Commerce filed last week argue the Inflation Reduction Act‘s (IRA) drug pricing negotiation provisions are unconstitutional and should be struck down.

Details on Merck’s lawsuit

Merck’s lawsuit, filed Tuesday of last week, argued the drug pricing negotiation process outlined in the IRA is a “sham” and a bureaucratic diktat in disguise, backed by coercive state sanctions rather than mutual consent that is “tantamount to extortion.”

Specifically, Merck claimed drug price negotiations will result in the government taking the company’s “private property,” violating the Fifth...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, HHS, Insurance, Medicare, Pharma, Pharma / Biotech
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
Key Trends in the Evolution of PBMs and Their Future Impact on Drug Pricing and Pharmacy Operations

Share This Article